Clinical Trial

A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study is a "3+3" dose-escalation, open-label, multiple-dose clinical trial.
Trial Details
NCT Number NCT07201064
Lead Sponsor Guangdong ProCapZoom Biosciences Co., Ltd.
Conditions Advanced Hepatocellular Carcinoma
Enrollment 12 participants
Start Date 2025-09-25
Primary Completion 2027-03-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-01